Results 131 to 140 of about 1,313,066 (193)
Quantitative susceptibility mapping and blood neurofilament light chain differentiate between parkinsonian disorders. [PDF]
Zhang P +8 more
europepmc +1 more source
Racial and geographic disparities with gastrostomy tube placement in dementia and parkinsonian disorders. [PDF]
Kim DS +6 more
europepmc +1 more source
Dopamine transporter SPECT imaging in Parkinson’s disease and parkinsonian disorders [PDF]
Akdemir ÜÖ, Bora Tokçaer A, Atay LÖ.
europepmc +1 more source
ABSTRACT Purpose Cerebrovascular reactivity (CVR) provides an important index of vascular health and is conventionally quantified using a hypercapnic gas or breath‐hold challenge in conjunction with blood‐oxygen‐level‐dependent functional magnetic resonance imaging (BOLD‐fMRI).
Abdoljalil Addeh +9 more
wiley +1 more source
A Systematic Review on Disease-Modifying Therapies in Parkinsonian Disorders. [PDF]
Eijsvogel PPNM +3 more
europepmc +1 more source
Locus Coeruleus Integrity from 7 T MRI Relates to Apathy and Cognition in Parkinsonian Disorders. [PDF]
Ye R +11 more
europepmc +1 more source
Case Report on Acquired Hepatocerebral Degeneration
ABSTRACT Acquired hepatocerebral degeneration (AHD) is an uncommon neurological manifestation of chronic liver disease, most often associated with portosystemic shunting. The disorder is characterised by a combination of movement abnormalities, cognitive decline, and psychiatric disturbance. Manganese accumulation within the basal ganglia, secondary to
Aamir Khan, Odai Jumma, Taram Nayab
wiley +1 more source
FDG PET in the differential diagnosis of degenerative parkinsonian disorders: usefulness of voxel-based analysis in clinical practice. [PDF]
Arnone A +14 more
europepmc +1 more source
Background:Higher-order visual processing deficits are well recognised in Parkinsonian disorders, but their clinical utility remains underexplored.Objective:To assess whether impairments in higher order visual predict cognitive impairment, disease ...
Rohan T Jepegnanam +12 more
core +1 more source
Objective Initially described in 1976, X‐linked dystonia parkinsonism (XDP) is a neurodegenerative disease that can be characterized by the presentation of dystonia and parkinsonism symptoms. Although this disease bears some resemblance to other neurodegenerative diseases in terms of symptomatology, the pathological signature of XDP is still unclear ...
Adelie Y.S. Tan +19 more
wiley +1 more source

